Opt-Out Testing in the ER May Boost HIV Testing Rates

Share this content:
Opt-Out Testing in the ER May Boost HIV Testing Rates
Opt-Out Testing in the ER May Boost HIV Testing Rates

THURSDAY, Jan. 21, 2016 (HealthDay News) -- "Opt-out" testing could significantly increase the number of patients who agree to be tested for HIV, according to research published online Jan. 19 in The BMJ.

The study, which involved 4,800 patients seen in the emergency department, is the first randomized controlled trial to evaluate consent for HIV testing. None of the patients involved had ever tested positive for the virus. The researchers divided the patients into three groups based on different approaches to offering HIV testing. The first group received an "opt-in" approach, which let them know that testing was available but they had to specifically request the test. The second group received an "active choice" approach and were directly asked if they wanted to be tested for the virus. The third group received the "opt-out" approach. These individuals were tested for HIV unless they specifically asked not to be screened.

The researchers found 38.0 percent of the patients in the "opt-in" group agreed to be tested for HIV. Meanwhile, 51.3 percent of those in the "active choice" group and 65.9 percent in the "opt-out" group accepted the HIV test.

"Our study provides evidence that small changes in wording can significantly affect patients' behavior and thus our understanding of their preferences and is crucial to providing patient centered care," study leader Juan Carlos Montoy, M.D., from the University of California, San Francisco, and colleagues write.

Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »